Loading organizations...
Delta G Ventures operates as a strategic advisory services firm dedicated to the life sciences industry. The company provides specialized consulting expertise, guiding organizations through complex challenges and strategic decision-making within the medical device and broader healthcare sectors. Its core offering involves leveraging deep industry knowledge to deliver actionable insights and support for its clientele.
The firm was established in 2015 by Glenn L. Criser, J.D., Lars A. Janson, M.B.A., and Edward G. Sabin. These founders, all seasoned medical device executives, launched the venture based on the insight that their collective, extensive experience in the life sciences could provide significant strategic value to other companies navigating this highly regulated and rapidly evolving landscape. Their shared background forms the foundation of the firm's expertise.
Delta G Ventures primarily serves businesses and organizations operating within the life sciences industry. The firm aims to be a trusted partner, assisting clients in achieving their objectives and fostering sustainable growth. Its long-term vision centers on continuing to offer expert strategic guidance, helping to shape successful outcomes for companies contributing to advancements in global health.
DeltaG Ventures has 1 tracked investment across 1 company. The latest tracked deal is $2.0M Seed in Haystack News in April 2015.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 1, 2015 | Haystack News | $2.0M Seed | — | 2048 Ventures, Actarus Funds, Altair Capital Management, American Express Ventures, Chloe Sladden, Digital Currency Group, Fyrefly VC, Garden City Companies, Hoxton Ventures, ONE WAY Ventures, Richmond Global Ventures, Rocketship.vc, Streamlined Ventures, Western Technology Investment, Larry Braitman, Lawrence Braitman, Michael Birch, Todd Ruppert, David Anderman, Peter Kellner, Inspovation Ventures, SGH Capital, Stanford |